Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03246529
Title A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM (GENESIS)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors BioLineRx, Ltd.
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU

No variant requirements are available.